bioXclusters plus is organizing several activities with their gateways in order to ease SME landing in our target markets. In this case, we are organizing a webinar to understand the Adelaide life sciences ecosystem (Australia) and to get to know the benefits offered to medical devices companies. The seminar will feature Marco Baccanti, Chief Executive of Health Industries South Australia and is open to all companies in the bioXclusters plus area.
Adelaide was ranked as the most cost-competitive city in Asia Pacific by KPMG on their Competitive Alternatives index. This webinar will give medical device companies from around the world an opportunity to learn how Adelaide, Australia, can help their business and break into the Asia-Pacific market using Australia as a launchpad. From R&D to manufacturing, from sales and marketing to distribution, Adelaide could become an interesting spot in Asia Pacific to establish their operations and grow their business in Asia Pacific.
At the webinar you will hear about Australia’s regulations and business culture, as well as Adelaide’s cost-effectiveness for life sciences companies such as:
- Manufacturing: How decades of experience in automotive and defense manufacturing could be applied to medical device manufacturing
- R&D: 43.5% cashback
- Sales, marketing and distribution:
Health Industries South Australia is a government agency helping life sciences companies to establish in Adelaide. In its role has signed recently a MoU with the bioXclusters plus alliance (as seen in our newsletter) which will help forge alliances between companies, research centers and hospitals on the two continents. Moreover, it will also help accelerate companies’ business results and resolve a common
problem for SMEs: landing in new markets.
Along with BioSA, HInSA represents more than 100 companies and research bodies in Adelaide, a city with a quickly growing healthcare and life sciences sector. The Adelaide healthcare and life sciences sector, BioMed City, is one of the largest in the southern hemisphere and receives more than AU$3.6 billions in investment.
The webinar is predicted to take up to one hour, having 30m lecture and 30m Q&A. It will take place at 10am Central European time on Tuesday 11th July 2017. REGISTER HERE
This seminar could become an opportunity for life science companies to know better Asia-Pacific Market. To that end HInSA is organizing an Australia Life Sciences Tour for European companies just before AusBiotech Conference. This will take place
9am to 5pm, Tuesday 24th October 2017, initiated by bioXclusters, open for all bioXclusters plus regions. Registrations should take place by 3rd July through this form.